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Biotin-containing analogs of a potent agonist (N6-phenyladenosine) and a potent antagonist (1,3-dipropyl- 
8-phenylxanthine) of adenosine receptor activity have been synthesized. A spacer chain to the biotin moiety 
is attached in both cases to the para-position of the phenyl ring. Two biotin conjugates of NQphenyladeno- 
sine differing only in the length of the spacer chain bind to the adenosine receptor and to avidin simultaneous- 
ly. The shorter-chain derivative was more potent in inhibiting binding of N6-[3H]cyclohexyladenosine to 
rat cerebral cortical membranes (K, of 11 nM in the absence of avidin, 36 nM for the avidin complex). Three 
biotin conjugates of 1,3-dipropyl-8-phenylxanthine bound competitively to the adenosine receptor, but only 
in the absence of avidin. The results are interpreted in terms of the possible orientation of the ligands at 
the receptor binding site. 
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1. INTRODUCTION 
The non-covalent avidin-biotin complex [l] 
forms rapidly, is remarkably stable, and has been 
used in a variety of manners as biochemical probes 
[2,3]. Biotin may be attached readily through its 
carboxyl group to a biologically active compound 
(pharmacophore) to afford a bifunctional entity, 
which still retains high affinity for avidin through 
its biotin component, and which has the potential 
to retain activity for its target site (receptor, en- 
zyme, transport protein) through its pharmaco- 
phore (see [4-111 for examples of use in receptor 
localization and purification and in drug delivery). 
We have introduced previously a series of 
ligands for the adenosine receptor which feature 
adenosine or xanthines covalently attached to 
chains bearing carboxylic or amino groups [ 12,131. 
These biologically active analogs may be attached 
to other molecules or ‘carriers’ through the car- 
boxy1 or amino groups: such analogs are termed 
functionalized ‘congeners’ following the nomen- 
clature of Goodman and co-workers [14]. Func- 
tionalized congeners of N6-phenyladenosine 
(agonists) and of 1,3-dialkyl-8-phenylxanthine (an- 
tagonists) bearing amino groups were chosen as the 
parent ligands for the attachment o biotin. The 
properties of biotin conjugates of adenosine recep- 
tor ligands in the absence and presence of avidin 
were used to investigate the accessibility of the 
ligand binding site(s) on adenosine receptors. 
2. MATERIALS AND METHODS 
Compounds 2a and 3a were prepared as 
reported previously [ 12,131 by acylation of the ap- 
propriate amino congener by d-biotin N-hydroxy- 
succinimide ster. Compounds 2b and 3b were syn- 
thesized in an analogous manner from the same 
functionalized congeners except that d-biotinyl-e- 
aminocaproic acid N-hydroxysuccinimide ester 
(Calbiochem) was the acylating agent. Compound 
3c was derived from the glycyl-glycine conjugate 
[12] of the 1,3_dipropylxanthine amino congener 
and d-biotinyl-e-aminocaproic acid N-hydroxy- 
succinimide ster. A typical acylation reaction con- 
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sisted of suspending lo-50 mg of the free amino- 
functionalized analog in several ml of dimethyl- 
formamide and treating the suspension with 1.2 
molar equivalents of either active ester derivative 
of biotin. After the reaction mixture was stirred 
for one day the product precipitated upon addition 
of small amounts of methanol and ether. The con- 
jugates were recrystallized from dimethylform- 
amide/ether, and the purity of each product was 
ascertained by thin layer chromatography (silica 
gel, chloroform/methanol/acetic acid, 85 : 10: 5) 
using a biotin-specific spray reagent [ 151 and ultra- 
violet light for visualization. The following solid 
products were obtained: 2b, 93% yield, mp 
195-198°C; 3b, 99%, mp 218-221°C; 3c, 85%, mp 
210-212.5”C. The biotin conjugates gave correct 
C, H, and N analyses (2b, 3b, and 3c as the 
monohydrates) and were characterized further by 
360 MHz proton NMR. 
Avidin (affinity purified), streptavidin, avidin- 
fluorescein isothiocyanate, and avidin-peroxidase 
(purified by affinity chromatography and gel 
! 
permeation chromatography) were obtained from 
Sigma. 
Assays of competitive binding of N6-[3H]cyclo- 
hexyladenosine on rat cerebral cortical membranes 
were carried out as described previously [13] using 
triplicate determinations. Binding assays in the 
presence of avidin were carried out after prein- 
cubating the biotin conjugate at varying concentra- 
tions and avidin at a fixed concentration for 
10 min in 50 mM Tris buffer (pH 7.7). 
Binding of biotin derivatives to avidin was 
measured by a modification of the procedure of 
Rylatt et al. [16] which involves saturation of 
unoccupied sites with [3H]biotin (New England 
Nuclear, 35 Ci/mmol) after preincubation of the 
avidin with varying amounts of the biotin 
derivative. The stable biotin-avidin complex was 
precipitated using alkaline zinc sulfate and isolated 
as a pellet by centrifugation. The pellet was 
resuspended and centrifuged to reduce baseline 
counts. Concentrations and conditions were as 
described by Kohanski and Lane [7]. 
22 Y =-NH-KH2)2NH- 
~y~~H2_o_&____C~2C~2CH~ ?_f’ Y=-NH’CH2’2NH- 
i C 2CH2CH3 
I 
I 
zb Y=-NHtCH215CONH(CH212NH- 
I 
3” Y=-NHKH2+$OINHCH2C0J2NHlCH2)2NH. 
Fig.1. Structures of biotin and biotin conjugates. 
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3. RESULTS 
Biotin was coupled to amino congeners of 
N6-phenyladenosine (agonists) and 1,3-dipropyl- 
8-phenylxanthine (antagonists) to give compounds 
2a and 3a, respectively. Similarly, conjugates 2b 
and 3b containing the c-aminocaproyl spacer 
group [6] were prepared to examine the relation- 
ship between chain length and activity in the bind- 
ing assay. In the antagonist series, an analog (3~) 
containing glycylglycine as an additional spacer 
was also prepared. 
The ability of the 5 biotin conjugates to inhibit 
competitively binding of N6-[3H]cyclohexyl- 
adenosine (CHA) to rat cerebral cortical mem- 
branes was used as a measure of the affinity for the 
central Ar-adenosine receptor ([13] and refs there- 
in). The adenosine conjugates (2a, 2b) had 
substantial affinity for the Al-receptor (table 1) 
albeit slightly reduced relative to the parent 
N6-phenyladenosine (Ki = 3.2 + 0.5 nM). The 
diminished potency of the conjugate having the 
aminocaproyl spacer group (2b) suggests a positive 
contribution of the biotin group when closer to the 
pharmacophore. 
The xanthine conjugates (3a, 3b, and 3c) were 
several-fold less potent at the Ar-adenosine recep- 
tor than the parent 1,3-dipropyl-8-phenylxanthine 
(Ki = 13 Z!Z 3 nM). Remarkably, the presence of the 
f-aminocaproyl spacer group in 3b does not affect 
the receptor affinity. Compound 3c having the 
longest spacer chain was the least potent in the an- 
tagonist series in binding at the Ar-adenosine 
Table 1 
Affinity constants for biotinylated ligands, from com- 
petitive binding assays of N6-[3H]cyclohexyladenosine to 
rat cerebral cortical membranes 
Compound Ki (nM] 
No avidin 1 pM avidin 
2a 11.4zko.4 36 
2b 18 * 1.7 35 
3a 54 *2 >500 
3b 50 kO.4 >500 
3c 60 >500 
Values are the mean of single experiments done in 
triplicate or the mean + SE of 2-6 experiments 
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receptor. The xanthine congeners were also active 
in an AZ-adenosine receptor esponse, viz., reversal 
of the cyclic AMP accumulation elicited by 
2-chloroadenosine in guinea-pig brain slices [ 131 
(Ki for compound 3a was 180 + 80 nM). 
Binding of the isolated conjugates to avidin was 
studied through the zinc sulfate precipitation of 
the stable complex [ 161. Binding sites not occupied 
by a biotin conjugate molecule were titrated with 
[3H]biotin (fig.2). All 5 of the biotin conjugates 
bound to the avidin tetramer in the predicted ratio 
of 4:l. 
To assess the efficiency of binding of the con- 
jugates simultaneously to the adenosine receptor 
and to avidin, the conjugates were pre-incubated 
with various concentrations of avidin to preform 
the complex and then tested in the competitive 
binding assay with [3H]cyclohexyladenosine. For 
compound 2a a family of curves resulted (fig.3), in 
0 
im 200 
L&rd Added (pm11 
Fig.2. Binding of compound 2a to avidin (60 pmoi). 
Fig.3. Inhibition of binding of N6-cyclohexyladenosine 
to rat cerebral cortical membranes by compound 2a. 
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which the binding profile was shifted to the right 
by avidin. At a large excess of avidin (100 nM in 
avidin tetramer, each containing 4 independent 
binding sites) the apparent Ki for 2a had increased 
from 11 to 36 nM. The long cabin biotin- 
adenosine conjugate (2b) also displayed 
simultaneous binding to avidin and to the 
adenosine receptor (fig.4). Avidin alone had no ef- 
fect on binding of [3H]cyclohexyladenosine until it 
reached micromolar concentration at which point 
lo-20% inhibition occurred. 
In contrast, the biotin-xanthine conjugates 
regardless of the length of the spacer chain bound 
to the receptor only in the absence of avidin. At a 
concentration of 1 FM in avidin subunits, the xan- 
thine conjugate 3a (fig.5) did not cause 50% in- 
hibition even at a concentration 8-fold greater than 
the IGo in the absence of avidin. 
The most potent adenosine conjugate, com- 
pound 2a, was then tested for Al-receptor binding 
- 
Fig.4. Inhibition of binding of N6-cyclohexyladenosine 
to rat cerebral cortical membranes by compound 2b. 
-25 nM Avldm 
-2.5 nM Avidm 
-No Avidtn 
4. DISCUSSION 
Fig.5. Inhibition of binding of I@-cyclohexyladenosine Pharmacophores attached to biotin have proven 
to rat cerebral cortical membranes by compound 3a. useful for the investigation of the topography of 
.Y 
% 
P 
0 
Cont. (MI 
Fig.6. Effects of the presence of avidin derivatives 
(100 nM) on the inhibition of binding of N6-cyclohexyl- 
adenosine to rat cerebral cortical membranes by com- 
pound 2a. H, adenosine-biotin conjugate; a, adenosine- 
biotin conjugate + avidin derivative; +, avidin 
derivative alone. 
in the presence of several avidin derivatives used in 
histochemical studies. Avidin coupled to fluores- 
cein isothiocyanate (average 3.5 equivalents per 
tetramer) or to peroxidase (average 1.5 equivalents 
per tetramer) was preincubated with compound 2a 
prior to the binding assays. The tetrameric protein 
streptavidin from Streptornyces avidinii, having 
less non-specific binding [ 171 than the glycoprotein 
avidin, was also examined. Streptavidin, like 
avidin, is a tetramer with 4 binding sites for biotin. 
These derivatives of avidin are virtually in- 
distinguishable from avidin in the effect on bind- 
ing of compound 2a to the receptor (fig.6). 
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macromolecular regognition sites [5], for histo- 
chemical localization [4] and for the purification 
of recognition sites [7]. Biotin conjugates of an 
adenosine receptor agonist and an adenosine 
receptor antagonist have now been prepared and 
used to investigate possible topographical con- 
straints at agonist and antagonist binding sites of 
Al-adenosine receptors. 
The adenosine conjugate 2a readily binds 
simultaneously to the Ai-adenosine receptor and to 
avidin: the Ki of 2a is reduced only by a factor of 
3 in the presence of excess avidin. In the simplest 
interpretation, the spacer chain of 17 atoms 
separating the biotin moiety from the p-amino 
group of adenine is sufficiently long to bridge the 
combined depth of both binding sites. It has been 
estimated [6] that the carboxyl group of biotin in 
the bound state is located at a maximum distance 
of 2 A from the surface of the avidin molecule. 
This distance leads to an estimated maximum limit 
of the depth of the binding site at the adenosine 
Al-receptor. From our results, the p-amino 
group of adenosine should be located in the bin- 
ding site at a depth of no greater than approx. 12 
A, based on the sum of the linear dimensions of 
the spacer chain in the extended conformation. 
These dimensions might be defined more narrowly 
through the synthesis and biochemical 
characterization of adenosine conjugates with even 
shorter spacer chains. 
The inability of the xanthine conjugates (3a, 3b, 
and 3c), having spacer chains up to 24 atoms in 
length, to bind simultaneously to the Ai-adenosine 
receptor and to avidin is surprising in view of 
results with the adenosine conjugates. One ex- 
planation is that the agonist and antagonist sites 
may be at different domains of the receptor, 
perhaps with the agonist site ‘buried’ much deeper. 
Alternatively, the domains may be the same, but 
the antagonist may bind so that the S-phenyl moie- 
ty is ‘buried’ more deeply within the site than is the 
N6-phenyl moiety of the agonist. Regardless of the 
interpretation, the present results provide evidence 
that a bulky macromolecule, i.e., the avidin-biotin 
complex, some 28 A from a potent antagonist 
pharmacophore (3~) prevents interaction at the 
Ai-adenosine receptor. In contrast, a bulky 
macromolecule (avidin-biotin complex) some 14 A 
from a potent agonist pharmacophore does not 
prevent interaction of the Al-adenosine receptor. 
34 
Whether other receptors will show analogous 
results with biotinylated agonists and antagonists 
deserves investigation. 
The present results also indicate that the ligand 
binding site of the adenosine receptor is located 
within of 12 A the surface of the membrane. Extra- 
cellular adenosine receptors were demonstrated 
previously through the cardiovascular activity of 
non-penetrating oligosaccharide conjugates of 
adenosine and theophylline [ 181. 
The accessibility of the adenosine receptor to 
agonist-biopolymer complexes suggests that con- 
siderable flexibility is possible in the design of 
receptor probes having bulky substituent groups at 
the end of a chain and in the design of carrier- 
bound therapeutic agents acting at the adenosine 
receptor. In particular, the biotinylated conjugates 
of adenosine have considerable potential as a 
bifunctional link between the adenosine receptor 
and avidin coupled to spectroscopic or enzymatic 
markers for localization studies or biochemical 
assays. 
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